Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Beta and ATRA for Anemia in Myelodysplastic Syndromes
NCT00437450Phase 2Unknown
- Sponsor
- Groupe Français des Myélodysplasies
- Start
- Oct 2004
- Modality
- Erythropoietins, Colony Stimulating Factors, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin beta, tretinoin in myelodysplastic syndrome (MDS), anemia, sponsored by Groupe Français des Myélodysplasies. Status: unknown.
02
Drugs
epoetin betatretinoin
03
Conditions
myelodysplastic syndrome (MDS)anemia
Beyond the preview
Go deeper on NCT00437450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437450.